title: Aseptic meningitis possibly induced by adalimumab.
authors.forename: Aurélie
authors.initials: A
authors.lastname: Jazeron
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Lallier
authors.forename: Boris
authors.initials: B
authors.lastname: Rihn
authors.forename: Marie-Catherine
authors.initials: MC
authors.lastname: Thiercelin
mesh_terms: D000068879:Adalimumab; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D005260:Female; D006801:Humans; D008582:Meningitis, Aseptic / Q000139:chemically induced* / Q000188:drug therapy / Q000473:pathology; D008875:Middle Aged
chemical_list: D000900:Anti-Bacterial Agents; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D018501:Antirheumatic Agents; D000068879:Adalimumab